The multifunctional zinc-finger protein CCCTC-binding factor (CTCF) is a very strong candidate for the role of coordinating the expression level of coding sequences with their three-dimensional position in the nucleus, apparently responding to a ''code'' in the DNA itself. Dynamic interactions between chromatin fibers in the context of nuclear architecture have been implicated in various aspects of genome functions. However, the molecular basis of these interactions still remains elusive and is a subject of intense debate. Here we discuss the nature of CTCF-DNA interactions, the CTCF-binding specificity to its binding sites and the relationship between CTCF and chromatin, and we examine data linking CTCF with gene regulation in the three-dimensional nuclear space. We discuss why these features render CTCF a very strong candidate for the role and propose a unifying model, the ''CTCF code,'' explaining the mechanistic basis of how the information encrypted in DNA may be interpreted by CTCF into diverse nuclear functions.
Introduction
Linear eukaryotic DNA is condensed $100,000-fold by packaging with nucleosomes into chromatin.
(1) The arrangement of chromatin within the nucleus is not random: at the interphase, de-condensed chromosomes occupy areas termed chromosome territories, (2, 3) which are dynamic compartments able to intermingle with each other. (4) Chromosomes are generally organized in radial positions in the nucleus, with most gene-poor chromosomes located close to the periphery, and gene-dense chromosomes toward the center of the nucleus. (5) Recent findings have indicated that the positioning of genes within the nucleus -in relation to other genes or nuclear structures -is important and is able to modulate gene function. (6) These patterns illustrate a general principle of nuclear organization -multiple, specialized nuclear compartments associated with particular biological functions (7) : transcription can take place at nuclear sites called ''transcription factories,'' DNA replication at ''replication factories,'' and DNA repair at specialized repair sites. (8) Such organization in the nucleus is likely to result from more or less stochastic interactions of self-assembling nuclear proteins, as demonstrated for Cajal bodies. (9) Importantly, the existence of specialized compartments provides opportunities for interactions (''crosstalk'') between chromatin fibers. Recent technological advancements, in particular the chromosome conformation capture (3C) method and its derivatives (Box 1), allow researchers to study interactions between chromatin regions at high resolution. These approaches are helping to reveal that there are non-random interactions between different regions of chromatin and that these chromatin interactions can influence the function of the genome. (10) (11) (12) In particular, they have been implicated in affecting transcription (3) and replication (13) in mammals. However, important questions remain as to how these specific interactions are set up, maintained, and controlled. A growing body of evidence suggests that the same highly conserved multifunctional protein CCCTC-binding factor (CTCF) is a universal ''master weaver'' of diverged genomes in all multicellular organisms, which may be important for coordinating the organization and regulation of a whole range of distinct genomic functions in three dimensions (recently reviewed by Phillips and Corces (14) ).
the DNA can be interpreted by CTCF into diverse nuclear functions.
CTCF and brother of the regulator of imprinted sites (BORIS)
CTCF (Table 1 and Fig. 1A ) was initially discovered as a transcriptional regulator that binds to a CT-rich region in the promoter of the chicken c-myc gene. (15) However, subsequent studies revealed that CTCF can recognize and bind to highly diverse sequences, (16) termed CTCF binding (or target) sites (CTSs). Numerous CTSs have now been identified in various genic and non-genic regions of the genome (including promoters, exons, introns, repeat elements, and others). (16) (17) (18) (19) The DNA binding domain of CTCF, which is highly conserved between species, is composed of 11 zinc fingers (ZFs). (16) The conservation of the CTCF protein from
Drosophila to human and its widespread expression in cells and tissues signify the importance of CTCF. Indeed, many cellular functions such as growth, proliferation, differentiation, apoptosis, imprinting, and X-chromosome inactivation are regulated by CTCF. (16, (20) (21) (22) Conditional CTCF knockout mouse models have demonstrated that CTCF is essential for cell cycle progression in ab T cells (23) and cytokine expression in T helper 2 cells. (24) Together with data obtained recently in Drosophila (25) and mammalian cell models, (26, 27) these results converge on regulation of cell cycle as one of the main functions of CTCF. Various post-translational modifications and interacting partners of CTCF have been identified (Fig. 1 and Table 2 ), which are likely to play an important role in CTCF function (see below). BORIS (Table 1) , also known as CTCFL (CTCF-like), is a paralog of CTCF. The 11ZF domain of BORIS is identical to that of CTCF at every amino acid relevant to DNA binding,
Box 1: Chromosome conformation capture (3C) methods
Awareness of the importance of the folding of chromosomes and how the chromatin fiber can establish both intra-and inter-chromosomal interactions prompted the development of methods to analyze, at high resolution, the frequency of interactions, and the sequences involved. The first method to be used for this purpose, DNA FISH, provides a measure of frequencies of physical juxtapositions. (2) Although still useful, its low resolution, >0.2 mm, precludes detailed analysis of the interacting regions. Moreover, the DNA FISH approach requires a prior knowledge of candidate interacting regions, which may generate a bias in interpretation. One of these pitfalls, the low resolution, was overcome by the 3C method. (108) The 3C method has proven very useful in determining close physical proximity of sequences (with a resolution of a few kilobases) from remote locations within formaldehyde-cross-linked chromatin. Briefly, cross-linked chromatin is opened up by detergents, digested with chosen restriction enzymes, and followed by ligation under very dilute conditions, which favors intramolecular ligation events. Subsequently, interacting chromatin fibers can be identified after reversal of the cross-links, using PCR primers representing either of the sequences of interest.
Another variation of 3C, termed ChIP-loop, combines the 3C analysis with chromatin immunopurification (ChIP) and allows determination of the interacting sequences that are dependent on a particular protein. (76, 107) However, the strategy of using defined PCR primers for either interacting sequence means that 3C is unsuitable where the sequences of interest are unknown. To deal with this shortcoming, alternative methods based on the 3C approach were developed. They are known as 4C techniques and were independently developed in two different laboratories. (86, 109, 110) The name-giving versions of the 4C techniques differ from the 3C method by the inclusion of a circularization step that enables the identification of interacting sequences using primers positioned on one of the sequences (the bait), but close to the junction between the bait and interacting sequence. This trick allows high throughput screening of physical interactions between chromosomes without a preconceived idea of the interacting partners of the sequence of interest. Despite similar strategies, there are fundamental differences in the details of the 4C techniques, such as what restriction enzyme(s) were used, at what stage the circular DNA is generated, and how the resulting PCR-amplified fragments were analyzed. As a further caveat, the 4C methods allow at best a semi-quantitative estimate of genome-wide patterns of interactions from particular baits. Moreover, their inability to readily assess the frequency of patterns of interactions necessitates complementing the 4C screens with DNA FISH analysis. The currently low sensitivity of the 4C technology (usually requiring at least a million cells) offers only snapshots of accumulated interactions. Thus, it should be expected that the number of interacting sequences is quite limited at any given time point and that dynamic on-off patterns of interactions generates a wide range of interacting sequences in large cell populations. Complete patterns of chromosomal fiber interactions with both unbiased interactor and bait will remain unattainable until a sufficiently affordable high throughput sequencing method has been developed. Moreover, there will be a need to develop 3C/4C-like techniques that are able to examine chromatin fiber interactions in individual cells and compare these, e.g., with chromatin states and cell cycle parameters.
suggesting that BORIS does not differ from CTCF with respect to recognition of the same set of DNA targets. (22, 28) The flanking N-and C-terminal domains of CTCF and BORIS are different, indicating distinct functions for these domains in the two proteins. In contrast to the ubiquitous CTCF, BORIS is primarily expressed in the testes of therian (placental and marsupial) mammals, in a mutually exclusive fashion with CTCF in mice and humans. (22, 28) (111) except primary spermatocytes (28) Primarily in spermatocytes in the testes of therian mammals in a mutually exclusive fashion with CTCF. (22, 28) Activated in a wide range of human cancers. (116) (117) (118) Localization Nuclear (111) Nuclear and cytoplasmic. (28) Functions Growth, proliferation, apoptosis, differentiation, imprinting, X-chromosome inactivation, genome integrity, candidate tumor suppressor (14, 16, 20, 22, 51) Linked with epigenetic reprogramming during germ-line development. (22, 28) Can function as a dominant-negative version of CTCF.
Identified orthologs
Chicken, (111) human, (47) mouse, (47) Xenopus, (112) Drosophila, (113) zebrafish, (114) cattle, (115) tammar wallaby, (115) platypus, (115) central bearded dragon (115) Human, (28) mouse, (28) cattle, (115) tammar wallaby, (115) platypus, (115) central bearded dragon (115) Molecular mechanisms Gene activation, repression, insulation and silencing (14, 16, 20, 22, 51) Initiation of methylation (119) or de-methylation events (117, 120) in context-dependent manners CTCF target sequences
Recognizes and binds to highly diverse sequences usually in methylation-sensitive manners (16, (20) (21) (22) Likely to recognize the same set of DNA targets as CTCF (22, 28) Table 2 ). 
CTCF-DNA interactions
What do consensus motifs for CTSs mean?
Identification of the consensus DNA sequence for the binding of a transcription factor is important for prediction of potential target sites and, subsequently, genes regulated by this factor. As prediction of the recognition motifs on the basis of the structure of DNA-binding proteins (including ZF factors) appears to be extremely difficult, (29) these motifs are usually determined experimentally, often in combination with bioinformatics tools.
Given the biological importance of CTCF, significant efforts have been made to elucidate the consensus motif for CTSs. Interestingly, analysis of the CTSs discovered prior to genome-wide screening highlighted the diverse nature of the CTSs, with individual CTSs having strikingly dissimilar primary DNA sequences. (16) This diversity made it very difficult to elucidate a single consensus motif to fit the CTSs then known. (30) (31) (32) More recently, a combination of computational methods and genome-wide screens has generated a number of CTCF ''consensus'' motifs for different organisms by independent approaches ( Fig. 2A) . (17, (33) (34) (35) (36) (37) (38) The three most consistent types of the consensus motif have been generated from the ChIP-seq datasets, which provide a better resolution compared to the ChIP-on-chip data. (39) The CTCF consensus motifs revealed both commonalities and discrepancies: some nucleotides were conserved at certain positions between species (''the invariant core,'' boxed in Fig. 2A ), whereas motifs identified even within the same species by independent means were not identical. The causes of these discrepancies might include the use of different antibodies that detect CTCF epitopes with different availability after formaldehyde cross-linking (a step in chromatin immunoprecipitation used in most genome-wide studies of CTCF binding), as well as the type of screening procedure adopted. A common problem of such genome-wide screening is that although high-affinity CTCF sites are well represented, there is poor coverage of CTSs weakly bound by CTCF. In addition, it recently emerged that ChIP assays generally have a bias for active chromatin, with heterochromatic regions being underrepresented; (40) this may also be relevant to genome-wide CTS detection assays. As discussed below, it is also possible that CTCF could mediate a loop formation between a CTS and a non-CTS. Presence of such non-CTSs, detected by ChIP, in the CTSs population may be an additional factor contributing to the controversial nature of the consensus. Owing in part to these experimental differences, the number of CTSs determined by genome-wide screening varies. The highest estimate is $40,000 CTSs in mouse ES cells. (35) A comprehensive ''CTCF binding sites database''
(http://insulatordb.utmem.edu) has been built (41) from CTSs obtained through genome-wide screens (17, 33, 42, 43) and a further 55 dissimilar CTSs that have been manually characterized (with respect to sequences occupied by CTCF and contact guanines responsible for contacts with CTCF ZFs). Of the CTSs collated from one of the genome-wide studies, the majority (46%) map to intergenic regions of the genome; the remaining CTSs are located in promoters (20%), exons (12%), and introns (22%). (17) Due to an only partial overlap between the sites identified by the different genome-wide screens, there is a need to experimentally assess the CTCF binding properties of subpopulations of CTSs that were identified in one report but not in others. The importance of such experimental validation is reinforced by the recent discovery of several functional CTSs that do not match any in-silico-generated CTSs consensus motif. Examples include CTSs in the hTERT (44) and ALF (45) gene promoters, and numerous methylation-sensitive and methylation-resistant CTSs in the promoter regions of the human BORIS gene (46) and in pericentromeric gamma-satellite DNA arrays. (18) Finally, the data on CTSs provided by genome-wide screening have limitations as although these studies present indications of the binding position, they only give approximations of the length of the region of DNA bound by CTCF.
What does determine the binding specificity of CTCF?
Early in CTCF research it was demonstrated that the sensitivity of CTCF-CTS complexes to proteases reflected the nature of the CTSs. (47) The realization that the utilization of the ZFs of CTCF for DNA binding might be CTS-specific, led to the development of the missing fingers approach. (47) By employing truncated versions of the ZF domain it was confirmed that, at least in vitro, different combinations of ZFs are employed depending on the sequence of the CTS (16) ( Fig. 2B ; for more examples see (16) ). Inline with these observations, naturally occurring tumor-specific point mutations in the CTCF ZFs completely altered the range of CTSs recognized by full-length CTCF (Fig. 2C) . (48) An interesting aspect of different utilization of binding surfaces by CTCF at different CTSs was shown by in vitro assays using binding sites 3 and 4 at the H19 imprinting control region (ICR). (49) CTCF-DNA complexes formed at site 3 and at site 4 were able to interact with each other through CTCF dimerization. However, interaction did not occur between two complexes bound at separate copies of site 3 or at separate copies of site 4 (illustrated in Fig. 1D ). This showed that the surfaces available for dimerization varied depending on the underlying CTS; this might have important functional implications (see below). Importantly, the pattern of guanine nucleotides that contact CTCF differs between individual CTSs, irrespective of (17) on plus and minus DNA strands; the invariant nucleotides are highlighted in gray. A match with the invariant core is indicated in the column in the middle. In human c-myc-A CTS, the mutation of ''G'' outside the consensus (indicated by the asterisk) leads to complete loss of CTCF binding. C: The effect of mutations in the CTCF ZF3 and ZF7 on CTS recognition. The range of CTSs recognized by CTCF carrying tumor-specific mutations of individual ZFs (48) in gel retardation experiments is shown. Filled boxes indicate strong binding, lighter boxes indicate partial loss of binding, and empty boxes indicate no binding. The mutations are: K344E, R339W, and H345R in ZF3 and R448Q in ZF7.
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R. Ohlsson, V. Lobanenkov and E. Klenova whether or not they conform to the consensus motif (16) ( Fig. 2B) . Moreover, as demonstrated in vitro (47) and in vivo (26) for the myc-A CTS, which is located immediately downstream of the c-myc P2 promoter, a single-base mutation of a ZF contact outside of the consensus region resulted in the loss of CTCF binding and abrogated activation of the c-myc P2 promoter in a stably chromatin-integrated reporter. (47) Also, naturally occurring mutations in CTSs can dramatically change the binding specificity of CTCF. This is exemplified by C-to-A or C-to-G mutations in a CTS at the À43 position relative to transcriptional start site of the XIST gene. Whereas the C(À43)A mutation abrogated CTCF binding (leading to inactive XIST), the C(À43)G mutation dramatically increased CTCF-binding efficiency (leading to active XIST). In addition, the C(À43)G mutation also altered the ZFs used by CTCF to contact the DNA; so CTCF used different contact nucleotides at the mutant site (Fig. 2B) . (50) Taken together, these observations suggest that a complex combination of the determinants (ZF utilization, the CTS primary sequence, and the CTS context) specify interactions between CTCF and CTSs. It is likely that, in vivo, these determinants have combinatorial effects that diversify CTCF function. In addition to these factors, chromatin context also affects CTCF binding; this is discussed in more detail below.
What do CTSs do?
The enhanced interest in CTCF during the last decade stems from the finding that mammalian chromatin insulators -with apparently no known exceptions -depend on CTSs (25, 51) (insulators are discussed further below). As a direct result of this interest, it is currently common in the literature to state that the presence of a CTS equals a chromatin insulator. However, experimental evidence shows that different CTSs are not equal and cannot readily functionally substitute for one another. For example, replacement of the H19 ICR by the b-globin insulator FII leads to the loss of imprinting. (52) Another study shows that mutation of just a single CTS in the cluster of four sites of the mouse H19 ICR results in deregulation of the whole locus and partial loss of imprinting. (49) In addition to insulation, CTSs have been linked with transcriptional repression (at the chicken and human MYC gene), (47) activation (at the APP gene), (53) silencing (at the chicken lysozyme gene), (54) control of transcriptional elongation, (55) chromatin domain boundaries that control the spread of non-coding RNA, (56) heterochromatinization, (56) and microsatellite repeat expansion. (57) While it is possible that CTSs will often display an insulator function in a plasmid-based insulator assay, these sites might, however, have other properties in other assays. 
CTCF and epigenetic states
In addition to the impact of nucleosomes on CTCF binding, CTCF binding to many (although not all) CTSs that contain CpG dinucleotides is dependent on these sequences being unmethylated. (49, (63) (64) (65) Conversely, mutations in CTSs and loss of CTCF binding in the maternal copy of the H19 ICR lead to hypermethylation (''paternalization'') of the maternal ICR (49, 63, 64) and acquisition of histone modifications that are characteristic of inactive chromatin across the H19 locus. (65) This pattern is consistent with observations that CTCF maps to predominantly methylation-free CTSs genome-wide. (42) Furthermore, CTCF-protein complexes might have an indirect inhibitory effect on the DNA methyltransferase Dnmt1 via PARP-1, resulting in DNA hypomethylation (66) (also see Table 2 ). The importance of controlling DNA methylation at CTSs is further illustrated by the example of the spinocerebellar ataxia type 7 (SCA7) loci. Here, a methylation-free status at the CTSs is necessary to control the CTG repeat extension; (57) such a mechanism may be common for many disorders resulting from microsatellite repeat expansion. In addition, CTCF binding to the CTS in the DM1 locus (56) can control the spread of the non-coding RNA and heterochromatin, thus restricting the CTG repeat expansion. Despite the diversity in the relationships between CTCF and epigenetic regulation reported so far, a common feature has recently emerged from the genome-wide studies. Although mainly correlative, these studies have found that the border between the repressive chromatin mark histone H3 trimethylated at lysine 27 (H3K27me3) and the active mark histone H2A acetylated at lysine 5 (H2AK5ac) are marked by CTCF. (33, 34) Another study showed that the borders of heterochromatic lamina-associated domains are also frequently separated by CTCF. (67) These observations raise the possibility that CTCF could maintain the local balance between active and repressive chromatin marks; this implies a need for cooperation between CTCF and chromatin modifiers. Indeed, association between CTCF and repressive complexes has been reported. (68) The conclusion from these observations is that the relationship between CTCF and chromatin is regulated in a complex manner through a variety of molecular mechanisms, including methylation-sensitive binding of CTCF to CTSs, nucleosome positioning, transcription of non-coding RNA, and regulation of local balance between active and repressive chromatin marks. As we discuss below, the link between CTCF and chromatin is likely to be crucial to explaining the mechanistic and functional aspects of interactions between different regions of DNA.
CTCF and three-dimensional aspects of genome function
It is now widely accepted that sub-chromosomal regions have a dynamic localization relative to nuclear compartments, where they encounter other parts of the genome. The trivial explanation for the existence of inter-and intra-chromosomal interactions is that they result from random collisions in the nucleus. However, a growing body of evidence demonstrates that close spatial proximity of genes might result from a sharing of common resources (69) (such as transcriptional machinery) and might also have regulatory functions in the selective activation or silencing of alleles. (70, 71) Although the mechanisms underlying spatial arrangement are currently poorly understood, observations relating to three-dimensional organization using the 3C technique and its derivatives (Box 1) are already significantly influencing our perspective of how gene functions are established and maintained by both cis-and trans-acting influences. In this section, we review current data that link CTCF with spatial regulation of genome functions.
Chromatin insulator and barrier function
Chromatin insulators are commonly defined as DNA elements that prevent inappropriate interactions between neighboring genes. Insulators are classified into enhancer blockers and barrier elements. Enhancer blockers prevent enhancerpromoter interactions if placed between these elements, thus repressing transcription. In contrast, chromatin barriers prevent spreading of heterochromatin (a repressive chromatin environment) into neighboring active domains. (72) The CTCF-insulator link was first demonstrated for the chicken HS4 element in the 5 0 boundary of the b-globin locus. (30) Subsequently, CTCF binding sites were identified at the H19 ICR insulator. (31, 73, 74) The number of characterized insulator sites increased with the development of a high throughput microarray analysis scoring for insulator functions. (42) However, common to all of these, and numerous other, reports is the use of plasmid systems with CTSs placed between enhancers and promoters of reporter genes; (75) i.e., testing for enhancer blocker activity. Such artificial systems suffer from a number of limitations: apart from poorly mimicking the chromatin context of endogenous CTSs, the plasmid systems do not allow an assessment of very longrange chromatin effects, which have emerged as a crucial element in the regulation of insulator function. (76) There is a strong possibility, therefore, that the insulator plasmid systems, irrespective of whether they are maintained episomally or incorporated into the genome, do not reflect an in vivo situation. To rigorously determine enhancer blocker function in vivo, there is a need not only to delete the insulator region, but also to insert the endogenous enhancer between the insulator and the transcriptional unit in question by genetic engineering approaches. Currently, the H19 ICR is the only mammalian insulator that has undergone such a robust in vivo analysis. (63, 64) It has for some time been unclear whether or not CTCF is involved also in chromatin barrier function. Although it was reported that the chromatin barrier at the 5 0 boundary of the chicken b-globin locus region contains no CTSs (77) and is CTCF-independent, three different recent reports have demonstrated that chromatin barrier functions can be CTCF-dependent: it was observed that CTSs in several instances demarcate repressive (H3K27me3) from active Review article R. Ohlsson, V. Lobanenkov and E. Klenova (H2AK5ac) domains in cell type-specific patterns; (34) gammasatellite sequences bind CTCF to protect against epigenetic silencing; (18) and the tumor suppressor gene p16INK4 can be aberrantly silenced by the eviction of CTCF from CTSs at or near a chromatin boundary. (27) Therefore it appears that at a subset of CTSs, CTCF binding has the ability to block either enhancing or silencing effects on transcriptional units.
Mechanisms of CTCF action in cis
The observations that long-range chromosome interactions are involved in the regulation of chromatin insulators hinted at two -not mutually exclusive -ways in which insulators might function. First, as exemplified by the Igf2-H19 (76) and MHC-II (78) loci, CTCF-dependent insulators can organize longrange interactions, which in turn may influence epigenetic states at key cis regulatory elements and affect transcription. Second, CTCF might drive the organization of insulated domains, probably via formation of loops and hubs, which restrict access to the transcriptional machinery. The active hub (ACH) concept (79) was first developed to suggest physical interaction in the nucleus between active b-globin genes and multiple cis-regulatory elements, whereas inactive genes were looped out. The role of CTCF in this system appears to be to regulate epigenetic states and long-range chromatin interactions, at the early stages of erythroid differentiation, with no effect on transcription. (80, 81) The latter finding is puzzling and may be explained by the presence of additional CTCF binding sites and/or different function of these CTSs in this locus.
The ACH concept provided a framework to explain CTCFmediated interchromosomal interactions in the Igf2 locus, which include several models. In the ''inactive loop'' model, the insulator is proposed to act as a topological barrier, creating a tight and transcriptionally inactive loop around the maternal Igf2 locus. (76) In the ''unproductive loop'' model, the insulator competes with the enhancer for promoters, acting as a promoter decoy for enhancers. (82) In the ''knotted loop'' model, the insulator forms a composite physical barrier (which might even involve interactions between different chromosomes) that blocks the access of all enhancers to Igf2, thereby silencing the maternal Igf2. (83) Irrespective of the specific model, the function of a loop would be to maintain, directly or indirectly, the silent state of the Igf2 at the maternal chromosome. Indeed, CTCF interacts with Suz12, a component of the PRC2 complex, (68) which establishes repressive H3K27me3 marks. The juxtaposition of PRC2 at the H19 ICR with the Igf2 promoter/DMR1 region might, via long-range chromatin fiber interaction and association to Pc bodies, contribute to the repressed status of the maternal Igf2 locus. However, it is noteworthy that the ICR insulator needs to be continuously present to suppress maternal Igf2 expression in somatic cells, suggesting that any such epigenetic mark is not stably maintained. (84) Exactly how this relates to the mechanism of enhancer function is not clear, although it has been argued that the H19 enhancer tracks along the chromatin fiber. (85) In this model, the H19 ICR insulator both provides a topological barrier and acts as a long-distance facilitator of repressed states.
CTCF action in trans
As the distribution of CTSs closely parallels gene density profiles, (17) the relationship between the gene density of chromosomes and their position within the nucleus is likely to influence the nuclear distribution of CTSs and thereby influence opportunities for CTCF-dependent chromatin fiber interactions. Although the data available are currently limited, the application of 3C and related techniques has provided data that support the existence of many CTCF-dependent trans-chromatin fibers. In these experiments, CTSs at the H19 ICR were shown to interact with a wide range of different loci both from the same and different chromosomes. (76, 86, 87) Furthermore, physical associations between chromatin fibers from different chromosomes were shown to affect transcription; e.g., deletion of the maternal H19 ICR allele on chromosome 7 led to alteration in the expression level of the Wsb1/Nf1 locus on chromosome 11. (87) Similarly, the expression levels of an imprinted domain on chromosome 18, the Osbpl1a/Impact locus, depended on CTSs of the maternal H19 ICR allele. (86) It is not yet known, however, whether it is CTCF itself, its interaction partners, or the physical interaction of the chromatin that influences transcription at these loci. The functions of CTCF-dependent complexes might also be linked to their positions relative to sub-nuclear compartments. For example, interaction of CTCF with nucleophosmin could possibly direct some CTSs to nucleoli, (88) and, as was recently demonstrated, to the nuclear membrane, in cooperation with lamin A. (89) The subset of CTSs that flank heterochromatic blocks, and possibly function as chromatin barrier, are likely to be found at the nuclear membrane where these blocks are often positioned. (67, 89) In combination with random or directed chromatin movements within and beyond the boundaries of chromosomal territories, localization to nuclear compartments can further diversify patterns of intraand inter-chromosomal interactions by providing different chromatin environments. For example, a transvection-like phenomenon in human cancer cells may rely on CTCF and its ability to relocate a subset of CTSs to the nucleolar compartment: at the nucleolus of mantle cell lymphoma cells, interaction between a CCND1 allele in its normal chromosomal location and a translocated allele might be dependent on CTCF-nucleophosmin complexes associated with key regulatory elements at the translocated allele. (90) Interestingly, the epigenetic status of the translocated allele was able to influence the methylation status of the non-rearranged CCND1 allele and hence influence its transcription potential. Similarly, it has been proposed that interaction between X-chromosomes in female mammals, during the counting phase of X-chromosome inactivation, might involve CTSs on X-chromosomes. (91, 92) The role of cohesin
For loops to form in a primary chromatin fiber, it has been suggested that the interacting sites must, by default, be at least 10 kb apart. (93) Higher-order chromatin conformations might impose further hindrances on chromatin folding. Of course, chromatin flexibility can be influenced by several factors, such as helicase activity. Interestingly, CTCF recruits CHD8, a chromatin-remodeling factor with helicase activity, to CTSs. (94) Thus, CHD8 could potentially release torsional stress that is hampering CTCF-dependent loop formation. It is not known how an encounter between chromatin fibers is initiated and then stabilized, although it has been proposed to involve distinct steps that reflect stochastic or directed chromatin movements. Once the physical distance between two chromosomal regions is sufficiently small, protein-DNA complexes might -perhaps transiently -stabilize the direct interaction between chromatin fibers. Members of the cohesin complex could play such a role. Cohesin complex binding extensively overlaps with CTSs in mammalian cells (37, 95, 96) and the majority of chromatin-cohesin associations are dependent on CTSs (Fig. 2A) . As CTCF (49) (Fig. 1D ) and cohesins (97) can homodimerize, it has been proposed that contact between two distal CTSs might be initiated via interaction between two CTCF and/or two cohesin molecules. Indeed, analysis of the molecular features of short-range (locus-specific) chromatin fiber interactions at the Ifng locus showed that the CTCF-cohesin complex regulates chromatin interactions within the Ifng locus in human T helper 1 cells. (98) Although the parental Ifng alleles have been shown to interact in trans to facilitate the kinetics of IFN-g expression upon pathogen insults, (99) in this case the CTCF-cohesin complex appears to be operating only in cis, consistent with the function of the cohesin complex in constraining chromosome topology.
The Ifng example described above suggests that the CTCF-cohesin complex might be specific to particular developmental or cellular stages. Similarly, contraction of the immunoglobulin heavy and light chain loci appears to involve stage-specific recruitment of the cohesin complex to CTSs during B cell development. (100) The concept that CTCF might interact stably with CTSs whereas the cohesin complex forms transiently at CTSs was further supported by the recent observation that the CTCF-cohesin association at chromatin peaks at mid-S phase and is dissolved during G2/M. (101) Such a dynamic behavior of the CTCF-cohesin interaction is consistent with the possibility that complexes of CTCF with other proteins (Table 2) vary between different cellular and chromosomal contexts.
A model for the diverse functions of CTCF
This review has summarized current evidence that has shown CTCF to be a versatile factor implicated in a large variety of nuclear functions. How can one factor be involved in such a range of biological processes? We believe that CTCF possesses features that might help to explain the molecular basis for organization of chromatin domains and epigenetic states both in cis and in trans. These features include: the presence of numerous binding sites (CTSs) -alone or in tandem -in the genome; the diversity of CTSs, resulting in the utilization of different ZFs; the ability of CTCF to interact with itself and/or with a wide range of protein partners; the regulation of CTCF by post-translational modifications (Fig. 1) ; and links between CTCF and epigenetic regulation. This combination of properties might be able to provide sufficient flexibility for the organization of dynamic nuclear chromatin domains and at the same time be able to provide specificity for selection of non-random interactions.
To draw together the diverse observations relating to CTCF function, we propose a unifying model, which we term the CTCF code (Fig. 3) . The central concept of this model is that CTCF can ''read'' the diverse functional information written in the DNA sequence of CTSs, such that differences in the nucleotide sequences, within or outside the consensus CTS motifs, can be sensed by various combinations of CTCF ZFs. As a result of using different ZFs to bind different CTSs, the exposed surface of CTCF that is available for interaction with another CTCF molecule (49) or with CTCF protein partners varies. Evidence for different CTSs having different intrinsic properties, for the differential utilization of ZF by different CTSs, and for the interaction between two different CTCFCTSs complexes (16, 49) has been discussed above. A direct association of certain CTSs with CTCF bound to specific protein partners has been demonstrated on a genome scale by serial ChIP analysis for CTCF-RNA polymerase II. (102) This type of analysis needs to be extended to other CTCF partners in order to test whether specific CTSs are consistently associated with specific CTCF-protein complexes.
The differences between the CTCF-DNA complexes that form at different CTSs across the genome might create a network of regulatory complexes that are capable of receiving, translating, and integrating intrinsic and extrinsic cues into functional outcomes. This model does not rule out the possibility of interactions between a CTCF complex and another type of protein complex, e.g., formed by another transcription factor at its cognate site (Fig. 3iii) . Post-
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R. Ohlsson, V. Lobanenkov and E. Klenova translational modifications of CTCF ( Fig. 1 ) (26, 27, 66, (103) (104) (105) might also contribute to the diversity of outcomes of CTCF binding and complex formation. Currently the data available to support this model are limited and are largely based on in vitro experiments. However, the model outlines predictions that can be tested in vivo, such as analysis of the CTSs bound by particular CTCF-protein complexes and identification of which proteins are associated with specific CTSs.
Conclusions
The large number of different CTSs across the genome and the apparent range of possible CTCF-protein interactions (''CTCF-interactome'') might be involved in the translation of a myriad of regulatory signals into specific nuclear functions. This could create a very extensive web of molecular interactions in the nucleus involving CTCF, its partners and CTSs. In order to elucidate the molecular details of CTCF action -and to test the concept of the CTCF code and the CTCF-interactome -further experimentations are required. These may include, e.g., elucidation of the biochemical properties of CTCF when it interacts with different CTSs, further characterization of the effect of missing ZFs, structural analysis of CTCF-CTSs complexes, as well as a more complete identification of proteins associated with specific CTSs in vivo. (106) Another aspect of CTCF function that warrants further investigation is whether and how it can act in an indirect manner, e.g., by maintaining methylation-free regions that would allow the binding of other protein factors.
Despite a large body of experimental data, the modus operandi of CTCF in the establishment of the long-distance interactions between chromatin fibers remains poorly understood. How can particular binding sites on separate chromosomes recognize each other amongst several tens of thousands of binding sites scattered all over the genome? This is a central issue in any approach that attempts to understand the mechanistic basis of long-range interactions between chromatin fibers. A plausible explanation is that the higher-order chromatin conformations of interacting chromosomes provide three-dimensional epigenetic information: an initial encounter that transiently generates an inter-chromosomal interaction facilitates protein-protein interactions that can stabilize specific interactions.
The fact that CTCF is expressed in most, if not all, somatic cells is one feature that makes it stands out amongst other key architectural nuclear factors, such as SatB1. (107) This expression pattern and the profound consequences of CTCF mutation and knock-down suggest that CTCF is an indispensable factor associated with essential functions in somatic cells. Given the relationship between CTCF and epigenetic modifications, it seems likely that CTCF complexes need to be dissolved during reprogramming events. In contrast to CTCF, BORIS expression is normally restricted to cells that are being epigenetically reprogrammed. Therefore it is possible that BORIS antagonizes CTCF interactions. Whether BORIS operates as a dominant-negative version of CTCF and/or as a CTCF-like factor able to establish other types of chromatin fiber interactions with its own set of protein partners remains to be determined. Our understanding of human diseases might also benefit from a research into how loss of CTCF functions can perturb nuclear architecture. One can envisage that disease-associated changes in CTCF-dependent features of the nuclear architecture might be owing to epigenetic changes at CTCF binding sites or changes at other levels including CTCF ZF mutations, lesions that affect post-translational modifications, Figure 3 . The CTCF code. Formation of diverse CTCF-protein complexes at different CTCF target sites (CTSs). The CTSs (CTS-1 and CTS-2) are recognized (''read'') by CTCF (blue line with ZFs shown as bars, and N-and C-terminal domains as an extension of the line). The red bars indicate the ZFs contacting the CTSs, and blue bars the ZFs that do not contact the CTSs. DNA is shown as a black line. Out of numerous possibilities we depict three general cases. In the first (i), CTCF uses different ZFs to contact two different CTSs. CTCF molecules bound at the two sites make direct contact with each other via, e.g., C-terminal ZF domain interactions (see Ref. (49) ). This brings together two CTSs. In the second example (ii), CTS-1 and CTS-2 are brought together by protein partners, which contact CTCF directly or indirectly via protein-protein bridges (green, red, and orange symbols in the image). Cohesin may act to stabilize the interactions in cases (i) and (ii), as demonstrated in Ref. (98) In the third example (iii), CTCF may directly (see, e.g., Ref. (92) ) or indirectly make contact with another DNA-binding trans-acting factor to bridge a CTS with a non-CTS. In this model, use of different ZFs at different CTSs results in different surfaces on CTCF being available for interaction with protein partners. The resulting combination of the CTCFCTSs-protein complexes specifies a particular nuclear function. According to the model, the underlying CTS determines the pattern of ZF utilization and hence the choice of protein partner in combination with post-translational modifications to dictate the functional outcome, as indicated in the figure. altered responses to signaling pathways, loss of function of CTCF protein partners, or the unscheduled activation of BORIS. Such effects could act locally or more globally, thus affecting the three-dimensional chromatin network in the whole nucleus in a pleiotropic manner. (69) Clearly, we are only seeing the beginning of a new and exciting research area that will improve our understanding of what functionally connects chromatin fibers within the nucleus.
